Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Use of glyburide for the treatment of gestational diabetes: the San Antonio experience

Conway, D. L., Gonzales, O., Skiver, D. · 2004 · The Journal of Maternal-Fetal & Neonatal Medicine

Abstract

OBJECTIVES: Equivalent efficacy of glyburide and insulin for treatment of gestational diabetes (GDM) was demonstrated in a recent randomized trial. We describe our experience with glyburide in practice, and suggest factors that predict failure of glyburide treatment. METHODS: Women with GDM treated with glyburide were studied. They were divided into two groups: those who achieved adequate glycemic control with glyburide, and those who did not. The groups were compared in terms of baseline characteristics, including diabetes risk factors and glucose testing values. Receiver operating characteristics (ROC) curves were generated to identify thresholds for fasting plasma glucose and body mass index (BMI) that would predict glyburide failure. RESULTS: Seventy-five women were analyzed: 63 (84%) were successfully treated with glyburide, and 12 (16%) were not. Baseline characteristics were similar between the groups, except that failures had higher 3-h glucose tolerance test (GTT) values at all time points. ROC curves for fasting plasma glucose, pre-pregnancy BMI and BMI at diagnosis revealed no cut-off points for predicting failure of glyburide therapy. However, when fasting plasma glucose value on the GTT was > or = 110 mg/dl, 24% of women failed to respond to glyburide, compared to 12% at < 110 mg/dl (p = 0.15). CONCLUSIONS: In treatment of GDM, glyburide is successful in achieving good glycemic control in most women. Women with high fasting plasma glucose levels, however, may not respond adequately to glyburide therapy.

Overview

Integrity signals

Registry

Crossref · 10.1080/14767050310001650725

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 3 references

Research works printed but not linked: 2

  1. Gilson G, 2002, Am J Obstet Gynecol, 187, S152
  2. American Diabetes Association, 2003, Gestational diabetesmellitus . Diabetes Care, 26, S103�5

Cited by

See all 112

Metadata

Authors
Conway, D. L., Gonzales, O., & Skiver, D.
Affiliations
The University of Texas at San Antonio Health Science Center (US)
Venue
The Journal of Maternal-Fetal & Neonatal Medicine
Published
2004-01-01
Volume
15
Issue
1
Pages
51-55
ISSN
  • 1476-4954 (ISSN-L)
  • 1476-7058
OpenAlex
W2020218807
Cited by
112
References
3
Citations by year
2026: 1 · 2025: 1 · 2023: 1 · 2022: 1 · 2021: 3 · 2020: 2 · 2019: 2 · 2018: 5 · 2017: 6 · 2016: 6 · 2015: 8 · 2014: 6 · 2013: 7 · 2012: 5
FWCI
10.85
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Maternal-Fetal & Neonatal Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
gestational diabetes mellitus, glibenclamide, glycemic control, insulin therapy, treatment failure prediction, fasting blood glucose, glucose tolerance test, body mass index, oral antidiabetic drugs
MeSH terms
Adult, Blood Glucose, Dose-Response Relationship, Drug, Drug Administration Schedule, Female, Glyburide, Humans, Hypoglycemic Agents, Pregnancy, Retrospective Studies, Texas, Randomized Controlled Trials as Topic, Diabetes, Gestational

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Use of glyburide for the treatment of gestational diabetes: the San Antonio experience. https://app.cochat.ai/papers/10.1080/14767050310001650725
The paper
Conway, D. L., Gonzales, O., & Skiver, D. (2004). Use of glyburide for the treatment of gestational diabetes: the San Antonio experience. The Journal of Maternal-Fetal & Neonatal Medicine. https://doi.org/10.1080/14767050310001650725

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.